Primary care physicians accounted for around 30 percent of opioid and naloxone prescriptions in the U.S. in 2018. Naxolone is used to block the effects of opioids and is used to treat opioid overdose.
Distribution of opioid and naloxone prescriptions dispensed in the U.S. in 2018, by prescriber specialty*
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$199 USD / Month *
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Other statistics that may interest you Canada's opioid crisis
Overview
8
- Basic Statistic Share of adults who followed the opioid issue in Canada in 2017, 2019, and 2020
- Basic Statistic Canadians who perceived opioid addiction and death as a serious problem as of 2020
- Basic Statistic Canadians who felt opioids were a problem in their community 2021, by gender
- Basic Statistic Share of Canadians who felt opioids were a problem in their community 2021, by age
- Basic Statistic Share of Canadians who felt opioids were a problem in their community 2021, by region
- Basic Statistic Canadians who perceived the opioid issue to have worsened or improved in 2020
- Basic Statistic Share of Canadians for or against policies to combat the opioid issue as of 2020
- Basic Statistic Share of Canadians who support select ideas to fight opioid use as of 2021
Opioid-related hospitalizations
8
- Premium Statistic Opioid poisoning hospitalization in Canada 2016-2022, by number and rate
- Premium Statistic Opioid poisoning hospitalization rates in Canada 2022, by province
- Basic Statistic Number of opioid-related hospitalizations in Canada from 2016 to 2022, by intention
- Basic Statistic Number of opioid-related hospitalizations in Canada in 2022, by age and gender
- Basic Statistic Distribution of opioid-related hospitalizations in Canada 2016-2022, by gender
- Premium Statistic Distribution of opioid-related hospitalizations in Canada 2016-2022, by age
- Basic Statistic Share of opioid-related hospitalizations in Canada 2016-2022, by drug involved
- Premium Statistic Share of opioid-related hospitalizations in Canada in 2022, by gender and province
Opioid-related overdose deaths
8
- Premium Statistic Number of opioid overdose deaths in Canada 2016-2022, by manner of death
- Premium Statistic Distribution of opioid overdose deaths in Canada 2016-2022, by gender
- Basic Statistic Distribution of opioid overdose deaths in Canada 2016-2022, by age
- Basic Statistic Share of opioid overdose deaths in Canada 2016-2022 that involved select drugs
- Basic Statistic Deaths from opioid overdose in Canada in 2022, by province
- Premium Statistic Death rate from opioid overdose in Canada in 2022, by province
- Basic Statistic Distribution of deaths from opioid overdose in Canadian provinces in 2022, by gender
- Premium Statistic Distribution of deaths from opioid overdose in Canada in 2022, by age
Further related statistics
10
- M&A capacities - changes for the global pharma industry 2008-2015
- Sales of Johnson & Johnson 2006-2023 by region
- CVS Health's total assets 2005-2023
- Walgreens gross profit and net earnings in the U.S. 2005-2023
- Medicinal market growth worldwide including rebates 2009-2018
- Expenditure worldwide on diabetes by market 2013-2018
- Chinese insulin market distribution: leading companies 2011
- U.S. insulin market distribution: leading companies 2011
- Global revenue share of EssilorLuxottica in 2022, by geographical area
- Sanofi's total assets 2007-2023
Further Content: You might find this interesting as well
Statistics
- M&A capacities - changes for the global pharma industry 2008-2015
- Sales of Johnson & Johnson 2006-2023 by region
- CVS Health's total assets 2005-2023
- Walgreens gross profit and net earnings in the U.S. 2005-2023
- Medicinal market growth worldwide including rebates 2009-2018
- Expenditure worldwide on diabetes by market 2013-2018
- Chinese insulin market distribution: leading companies 2011
- U.S. insulin market distribution: leading companies 2011
- Global revenue share of EssilorLuxottica in 2022, by geographical area
- Sanofi's total assets 2007-2023
CDC, & MMWR. (August 9, 2019). Distribution of opioid and naloxone prescriptions dispensed in the U.S. in 2018, by prescriber specialty* [Graph]. In Statista. Retrieved June 10, 2024, from https://internal.statista.com/statistics/1036745/opioid-and-naloxone-prescribing-distribution-us-by-prescriber-specialty/
CDC, und MMWR. "Distribution of opioid and naloxone prescriptions dispensed in the U.S. in 2018, by prescriber specialty* ." Chart. August 9, 2019. Statista. Accessed June 10, 2024. https://internal.statista.com/statistics/1036745/opioid-and-naloxone-prescribing-distribution-us-by-prescriber-specialty/
CDC, MMWR. (2019). Distribution of opioid and naloxone prescriptions dispensed in the U.S. in 2018, by prescriber specialty* . Statista. Statista Inc.. Accessed: June 10, 2024. https://internal.statista.com/statistics/1036745/opioid-and-naloxone-prescribing-distribution-us-by-prescriber-specialty/
CDC, and MMWR. "Distribution of Opioid and Naloxone Prescriptions Dispensed in The U.S. in 2018, by Prescriber Specialty* ." Statista, Statista Inc., 9 Aug 2019, https://internal.statista.com/statistics/1036745/opioid-and-naloxone-prescribing-distribution-us-by-prescriber-specialty/
CDC & MMWR, Distribution of opioid and naloxone prescriptions dispensed in the U.S. in 2018, by prescriber specialty* Statista, https://internal.statista.com/statistics/1036745/opioid-and-naloxone-prescribing-distribution-us-by-prescriber-specialty/ (last visited June 10, 2024)
Distribution of opioid and naloxone prescriptions dispensed in the U.S. in 2018, by prescriber specialty* [Graph], CDC, & MMWR, August 9, 2019. [Online]. Available: https://internal.statista.com/statistics/1036745/opioid-and-naloxone-prescribing-distribution-us-by-prescriber-specialty/